ArticleThe Journal of clinical investigation2005

Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.

Dengshun Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.